Cargando…
RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline
The purpose of this review article is to familiarize radiologists with the recently revised Response Evaluation Criteria in Solid Tumours (RECIST), used in many anticancer drug trials to assess response and progression rate. The most important modifications are: a reduction in the maximum number of...
Autores principales: | van Persijn van Meerten, Els L., Gelderblom, Hans, Bloem, Johan L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872013/ https://www.ncbi.nlm.nih.gov/pubmed/20033179 http://dx.doi.org/10.1007/s00330-009-1685-y |
Ejemplares similares
-
Response Evaluation and Survival Prediction Following PD‐1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria
por: Zhou, Meng, et al.
Publicado: (2021) -
RECIST rules
por: Sohaib, Aslam
Publicado: (2012) -
Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival
por: Manitz, Juliane, et al.
Publicado: (2022) -
The α-RECIST (RECIST 1.1 Combined With Alpha Fetoprotein): A Novel Tool for Identifying Tumor Response of Conversion-Radiotherapy for Unresectable Hepatocellular Carcinoma Before Hepatectomy
por: Xu, Ying, et al.
Publicado: (2022) -
iRECIST: how to do it
por: Persigehl, Thorsten, et al.
Publicado: (2020)